Class V lupus nephritis recurrence with histologic resolution in a kidney transplant recipient on a pregnancy-adapted immunosuppression protocol: a lesson for the clinical nephrologist
J Nephrol. 2024 Mar 26. doi: 10.1007/s40620-024-01920-z. Online ahead of print.NO ABSTRACTPMID:38530604 | DOI:10.1007/s40620-024-01920-z (Source: Journal of Nephrology)
Source: Journal of Nephrology - March 26, 2024 Category: Urology & Nephrology Authors: Jorane-Tiana Robert Ajay Rajaram Pierre O Fiset Chantal Bernard Ratna Samanta Shaifali Sandal Source Type: research
Anti-SSA Ro52 and anti-Ro60 autoantibodies: association with clinical phenotypes
CONCLUSIONS: Anti-Ro52+ antibody alone is frequently found in patients with non-rheumatic diseases. In addition, anti-Ro52+ antibody is also prevalent in patients with CTD and associated with clinical phenotypes that are different from anti-Ro60+ antibody.PMID:38530658 | DOI:10.55563/clinexprheumatol/puxml7 (Source: Clinical and Experimental Rheumatology)
Source: Clinical and Experimental Rheumatology - March 26, 2024 Category: Rheumatology Authors: Carolina Mazeda Natacha Oliveira Catarina Abreu Vanessa Fraga Isabel Maduro Andr é Saraiva Lu ís Inês Carla Ferreira Ana Margarida Correia Rafaela Nicolau Filipa Farinha Ingrid Villanueva Diogo Jesus Pedro Abreu Agna Neto Joana Silva Dinis Anabela Barc Source Type: research
Non-Lupus Full House Nephropathy
CONCLUSIONS: Our data support that SLE and non-lupus full house nephropathy are distinct clinical entities, with comparable outcomes. A small subset of patients develops SLE during follow-up. Non-lupus full house nephropathy is addressed by many different names in the literature. The identification of three pathogenetic categories provides further clues for the management of the disease.PMID:38527995 | DOI:10.2215/CJN.0000000000000438 (Source: Clinical Journal of the American Society of Nephrology : CJASN)
Source: Clinical Journal of the American Society of Nephrology : CJASN - March 26, 2024 Category: Urology & Nephrology Authors: Martina Uzzo Andreas Kronbichler Federico Alberici Ingeborg Bajema Source Type: research
Class V lupus nephritis recurrence with histologic resolution in a kidney transplant recipient on a pregnancy-adapted immunosuppression protocol: a lesson for the clinical nephrologist
J Nephrol. 2024 Mar 26. doi: 10.1007/s40620-024-01920-z. Online ahead of print.NO ABSTRACTPMID:38530604 | DOI:10.1007/s40620-024-01920-z (Source: Journal of Nephrology)
Source: Journal of Nephrology - March 26, 2024 Category: Urology & Nephrology Authors: Jorane-Tiana Robert Ajay Rajaram Pierre O Fiset Chantal Bernard Ratna Samanta Shaifali Sandal Source Type: research
Non-Lupus Full House Nephropathy
CONCLUSIONS: Our data support that SLE and non-lupus full house nephropathy are distinct clinical entities, with comparable outcomes. A small subset of patients develops SLE during follow-up. Non-lupus full house nephropathy is addressed by many different names in the literature. The identification of three pathogenetic categories provides further clues for the management of the disease.PMID:38527995 | DOI:10.2215/CJN.0000000000000438 (Source: Clinical Journal of the American Society of Nephrology : CJASN)
Source: Clinical Journal of the American Society of Nephrology : CJASN - March 26, 2024 Category: Urology & Nephrology Authors: Martina Uzzo Andreas Kronbichler Federico Alberici Ingeborg Bajema Source Type: research
Non-Lupus Full House Nephropathy
CONCLUSIONS: Our data support that SLE and non-lupus full house nephropathy are distinct clinical entities, with comparable outcomes. A small subset of patients develops SLE during follow-up. Non-lupus full house nephropathy is addressed by many different names in the literature. The identification of three pathogenetic categories provides further clues for the management of the disease.PMID:38527995 | DOI:10.2215/CJN.0000000000000438 (Source: Clinical Journal of the American Society of Nephrology : CJASN)
Source: Clinical Journal of the American Society of Nephrology : CJASN - March 26, 2024 Category: Urology & Nephrology Authors: Martina Uzzo Andreas Kronbichler Federico Alberici Ingeborg Bajema Source Type: research
Non-Lupus Full House Nephropathy
CONCLUSIONS: Our data support that SLE and non-lupus full house nephropathy are distinct clinical entities, with comparable outcomes. A small subset of patients develops SLE during follow-up. Non-lupus full house nephropathy is addressed by many different names in the literature. The identification of three pathogenetic categories provides further clues for the management of the disease.PMID:38527995 | DOI:10.2215/CJN.0000000000000438 (Source: Clinical Journal of the American Society of Nephrology : CJASN)
Source: Clinical Journal of the American Society of Nephrology : CJASN - March 26, 2024 Category: Urology & Nephrology Authors: Martina Uzzo Andreas Kronbichler Federico Alberici Ingeborg Bajema Source Type: research
Non-Lupus Full House Nephropathy
CONCLUSIONS: Our data support that SLE and non-lupus full house nephropathy are distinct clinical entities, with comparable outcomes. A small subset of patients develops SLE during follow-up. Non-lupus full house nephropathy is addressed by many different names in the literature. The identification of three pathogenetic categories provides further clues for the management of the disease.PMID:38527995 | DOI:10.2215/CJN.0000000000000438 (Source: Clinical Journal of the American Society of Nephrology : CJASN)
Source: Clinical Journal of the American Society of Nephrology : CJASN - March 26, 2024 Category: Urology & Nephrology Authors: Martina Uzzo Andreas Kronbichler Federico Alberici Ingeborg Bajema Source Type: research
Non-Lupus Full House Nephropathy
CONCLUSIONS: Our data support that SLE and non-lupus full house nephropathy are distinct clinical entities, with comparable outcomes. A small subset of patients develops SLE during follow-up. Non-lupus full house nephropathy is addressed by many different names in the literature. The identification of three pathogenetic categories provides further clues for the management of the disease.PMID:38527995 | DOI:10.2215/CJN.0000000000000438 (Source: Clinical Journal of the American Society of Nephrology : CJASN)
Source: Clinical Journal of the American Society of Nephrology : CJASN - March 26, 2024 Category: Urology & Nephrology Authors: Martina Uzzo Andreas Kronbichler Federico Alberici Ingeborg Bajema Source Type: research
Non-Lupus Full House Nephropathy
CONCLUSIONS: Our data support that SLE and non-lupus full house nephropathy are distinct clinical entities, with comparable outcomes. A small subset of patients develops SLE during follow-up. Non-lupus full house nephropathy is addressed by many different names in the literature. The identification of three pathogenetic categories provides further clues for the management of the disease.PMID:38527995 | DOI:10.2215/CJN.0000000000000438 (Source: Clinical Journal of the American Society of Nephrology : CJASN)
Source: Clinical Journal of the American Society of Nephrology : CJASN - March 26, 2024 Category: Urology & Nephrology Authors: Martina Uzzo Andreas Kronbichler Federico Alberici Ingeborg Bajema Source Type: research
Non-Lupus Full House Nephropathy
CONCLUSIONS: Our data support that SLE and non-lupus full house nephropathy are distinct clinical entities, with comparable outcomes. A small subset of patients develops SLE during follow-up. Non-lupus full house nephropathy is addressed by many different names in the literature. The identification of three pathogenetic categories provides further clues for the management of the disease.PMID:38527995 | DOI:10.2215/CJN.0000000000000438 (Source: Clinical Journal of the American Society of Nephrology : CJASN)
Source: Clinical Journal of the American Society of Nephrology : CJASN - March 26, 2024 Category: Urology & Nephrology Authors: Martina Uzzo Andreas Kronbichler Federico Alberici Ingeborg Bajema Source Type: research
Non-Lupus Full House Nephropathy
CONCLUSIONS: Our data support that SLE and non-lupus full house nephropathy are distinct clinical entities, with comparable outcomes. A small subset of patients develops SLE during follow-up. Non-lupus full house nephropathy is addressed by many different names in the literature. The identification of three pathogenetic categories provides further clues for the management of the disease.PMID:38527995 | DOI:10.2215/CJN.0000000000000438 (Source: Clinical Journal of the American Society of Nephrology : CJASN)
Source: Clinical Journal of the American Society of Nephrology : CJASN - March 26, 2024 Category: Urology & Nephrology Authors: Martina Uzzo Andreas Kronbichler Federico Alberici Ingeborg Bajema Source Type: research
Non-Lupus Full House Nephropathy
CONCLUSIONS: Our data support that SLE and non-lupus full house nephropathy are distinct clinical entities, with comparable outcomes. A small subset of patients develops SLE during follow-up. Non-lupus full house nephropathy is addressed by many different names in the literature. The identification of three pathogenetic categories provides further clues for the management of the disease.PMID:38527995 | DOI:10.2215/CJN.0000000000000438 (Source: Clinical Journal of the American Society of Nephrology : CJASN)
Source: Clinical Journal of the American Society of Nephrology : CJASN - March 26, 2024 Category: Urology & Nephrology Authors: Martina Uzzo Andreas Kronbichler Federico Alberici Ingeborg Bajema Source Type: research
Unveiling the role of tRNA-derived small RNAs in MAPK signaling pathway: implications for cancer and beyond
tRNA-derived small RNAs (tsRNAs) are novel small non-coding RNAs originating from mature or precursor tRNAs (pre-tRNA), typically spanning 14 to 30 nt. The Mitogen-activated protein kinases (MAPK) pathway orchestrates cellular responses, influencing proliferation, differentiation, apoptosis, and transformation. tsRNAs influence the expression of the MAPK signaling pathway by targeting specific proteins within the pathway. Presently, four MAPK-linked tsRNAs have implications in gastric cancer (GC) and high-grade serous ovarian cancer (HGSOC). Notably, tRF-Glu-TTC-027 and tRF-Val-CAC-016 modulate MAPK-related protein expres...
Source: Frontiers in Genetics - March 26, 2024 Category: Genetics & Stem Cells Source Type: research
Unraveling IFN-I response dynamics and TNF crosstalk in the pathophysiology of systemic lupus erythematosus
DiscussionWe provide a solid droplet-based microfluidic platform to study inherent immune secretory behaviors, substantiated by ODE modeling, which can challenge the conceptualization within and between different immune signaling systems. These insights will build towards an improved fundamental understanding on single-cell decision-making in health and disease. (Source: Frontiers in Immunology)
Source: Frontiers in Immunology - March 26, 2024 Category: Allergy & Immunology Source Type: research